Terms: = Liver cancer AND RPL5, 6125, P46777, MSTP030, MGC117339, ENSG00000122406 AND Prognosis
3 results:
1. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis.
Zhang YZ; Zeb A; Cheng LF
Front Immunol; 2022; 13():1032819. PubMed ID: 36439183
[TBL] [Abstract] [Full Text] [Related]
3. Low expression of moonlight gene ALAD is correlated with poor prognosis in hepatocellular carcinoma.
Ye Q; Yang X; Zheng S; Mao X; Shao Y; Xuan Z; Huang P
Gene; 2022 May; 825():146437. PubMed ID: 35318110
[TBL] [Abstract] [Full Text] [Related]
